Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Enzinger

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Investigational New Drugs|July 30, 2011
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancerJason E Faris, Jamie Arnott, Hui Zheng, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2006
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancerAndrew X Zhu, Jeffrey W Clark, David P Ryan, et al.
Pancreas|November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine TumorsKimberly Perez, Matthew H Kulke, Nora K Horick, et al.
JCO Precision Oncology|April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancerShuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 22, 2015
The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and RadiationRona Spector, Yifan Zheng, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumorsMatthew H Kulke, Emily K Bergsland, David P Ryan, et al.
Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.
Advances in Radiation Oncology|May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution ExperienceShane S Neibart, Katie N Lee, Yu-Hui Chen, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Investigational New Drugs|July 30, 2011
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancerJason E Faris, Jamie Arnott, Hui Zheng, et al.
Cancer Chemotherapy and Pharmacology|June 21, 2006
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancerAndrew X Zhu, Jeffrey W Clark, David P Ryan, et al.
Pancreas|November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine TumorsKimberly Perez, Matthew H Kulke, Nora K Horick, et al.
JCO Precision Oncology|April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancerShuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 22, 2015
The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and RadiationRona Spector, Yifan Zheng, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumorsMatthew H Kulke, Emily K Bergsland, David P Ryan, et al.
Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.
Advances in Radiation Oncology|May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution ExperienceShane S Neibart, Katie N Lee, Yu-Hui Chen, et al.
Pageof 10